Drug Developed Using Drdo Technology

A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday.

The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.

A host of technologies - meant to counter the threat of nuclear, chemical and biological warfare -- developed by India's defense research organization DRDO were handed over to the army on Thursday. The technologies also included India's first indigenously made weapons locating radar and a number of drugs to combat radiation sickness and minimize th...

A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday.

The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.

A host of technologies - meant to counter the threat of nuclear, chemical and biological warfare -- developed by India's defense research organization DRDO were handed over to the army on Thursday. The technologies also included India's first indigenously made weapons locating radar and a number of drugs to combat radiation sickness and minimize th...